跳至主要内容
临床试验/DRKS00015647
DRKS00015647招募中3 期

Efficacy and Safety of Fractionated Stereotactic Radiation Therapy (FSRT) versus Single Fraction Stereotactic Radiosurgery (SRS) for Large Brain Metastases (2 - 4 cm) - FSRT-Trial

niversitätsklinikum Erlangen0 个研究点目标入组 382 人开始时间: 2018年10月5日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
382

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Age = 18 years (no upper age limit)
  • 2. Karnofsky Performance Scale (KPS) score >50
  • 3. Life expectancy > 3 months
  • 4. 1 to 10 brain metastases from a solid tumor
  • 5. Indication for local radiotherapy of one or more brain metastases measuring 2 to 4 cm in diameter
  • 6. Ability to understand the contents of the protocol and consent to participate, in writing
  • 7. Written informed consent before enrollment in the study

排除标准

  • 1. Whole brain radiotherapy completed = 6 weeks before study treatment or planned whole brain radiotherapy following local radiotherapy
  • 2. Prior radiotherapy of the metastasis or metastases to be irradiated in the present study
  • 3. Relevant overlap of prior radiotherapy fields, cerebral or otherwise, with the metastasis or metastases to be irradiated in the present study
  • 4. Location of metastasis to be irradiated in the brainstem.
  • 5. Contraindications to magnetic resonance imaging (e.g., metal implants, cardiac pacemaker, claustrophobia)
  • 6. If a metastasis to be irradiated cannot be adequately differentiated in high-resolution, contrast-enhanced T1-weighted imaging for target volume delineation
  • 7. Pregnant or nursing women
  • 8. Women and men of reproductive age who are unwilling or unable to ensure reliable contraception during treatment
  • 9. Chronic drug, medication or alcohol abuse
  • 10. Psychological, familial, sociological, or geographical condition that would preclude study compliance
  • 11. Nursing care patients
  • 12. Inability to speak and understand German
  • 13. Simultaneous participation in another clinical trial

研究者

发起方
niversitätsklinikum Erlangen

相似试验